Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Selection of potential predictors of worsening heart failure: rational and design of the SELENE HF study.

Padeletti L, Botto GL, Curnis A, De Ruvo E, D'Onofrio A, Gronda E, Ricci RP, Vado A, Zanotto G, Zecchin M, Antoniou X, Gargaro A.

J Cardiovasc Med (Hagerstown). 2015 Nov;16(11):782-9. doi: 10.2459/JCM.0000000000000171.

PMID:
25036269
2.

Device diagnostics and early identification of acute decompensated heart failure: a systematic review.

Blair TL.

J Cardiovasc Nurs. 2014 Jan-Feb;29(1):68-81. doi: 10.1097/JCN.0b013e3182784106. Review.

PMID:
23369854
3.

Implantable cardioverter defibrillators for the treatment of arrhythmias and cardiac resynchronisation therapy for the treatment of heart failure: systematic review and economic evaluation.

Colquitt JL, Mendes D, Clegg AJ, Harris P, Cooper K, Picot J, Bryant J.

Health Technol Assess. 2014 Aug;18(56):1-560. doi: 10.3310/hta18560. Review.

4.

Effectiveness of implantable cardioverter defibrillators and cardiac resynchronization therapy in heart failure.

Freeman JV, Masoudi FA.

Heart Fail Clin. 2013 Jan;9(1):59-77. doi: 10.1016/j.hfc.2012.09.006. Epub 2012 Oct 13. Review.

PMID:
23168318
5.

Temporal Influence of Heart Failure Hospitalizations Prior to Implantable Cardioverter Defibrillator or Cardiac Resynchronization Therapy With Defibrillator on Subsequent Outcome in Mild Heart Failure Patients (from MADIT-CRT).

Lee AY, Moss AJ, Ruwald MH, Kutyifa V, McNitt S, Polonsky B, Zareba W, Ruwald AC.

Am J Cardiol. 2015 May 15;115(10):1423-7. doi: 10.1016/j.amjcard.2015.02.029. Epub 2015 Feb 18.

PMID:
25817576
6.

Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study.

Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM; PARTNERS Study Investigators.

J Am Coll Cardiol. 2010 Apr 27;55(17):1803-10. doi: 10.1016/j.jacc.2009.11.089.

7.

Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.

Biton Y, Kutyifa V, Cygankiewicz I, Goldenberg I, Klein H, McNitt S, Polonsky B, Ruwald AC, Ruwald MH, Moss AJ, Zareba W.

Circ Heart Fail. 2016 Feb;9(2):e002667. doi: 10.1161/CIRCHEARTFAILURE.115.002667.

8.

Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate CorRelation to Symptoms in Patients with Heart Failure (PARTNERS HF).

Whellan DJ, O'Connor CM, Ousdigian KT, Lung TH; PARTNERS HF Study Investigators.

Am Heart J. 2008 Nov;156(5):833-9, 839.e2. doi: 10.1016/j.ahj.2008.06.036. Epub 2008 Sep 23.

PMID:
19061695
9.

Impact of cardiac resynchronization therapy on hospitalizations in the Resynchronization-Defibrillation for Ambulatory Heart Failure trial.

Gillis AM, Kerr CR, Philippon F, Newton G, Talajic M, Froeschl M, Froeschl S, Swiggum E, Yetisir E, Wells GA, Tang AS.

Circulation. 2014 May 20;129(20):2021-30. doi: 10.1161/CIRCULATIONAHA.112.000417. Epub 2014 Mar 7.

10.

Potential value of automated daily screening of cardiac resynchronization therapy defibrillator diagnostics for prediction of major cardiovascular events: results from Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) study.

Sack S, Wende CM, Nägele H, Katz A, Bauer WR, Barr CS, Malinowski K, Schwacke H, Leyva F, Proff J, Berdyshev S, Paul V.

Eur J Heart Fail. 2011 Sep;13(9):1019-27. doi: 10.1093/eurjhf/hfr089.

11.

Inverse Relationship of Blood Pressure to Long-Term Outcomes and Benefit of Cardiac Resynchronization Therapy in Patients With Mild Heart Failure: A Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy Long-Term Follow-Up Substudy.

Biton Y, Moss AJ, Kutyifa V, Mathias A, Sherazi S, Zareba W, McNitt S, Polonsky B, Barsheshet A, Brown MW, Goldenberg I.

Circ Heart Fail. 2015 Sep;8(5):921-6. doi: 10.1161/CIRCHEARTFAILURE.115.002208. Epub 2015 Jul 15.

12.

Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study.

Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M.

Circulation. 2012 Jun 19;125(24):2985-92. doi: 10.1161/CIRCULATIONAHA.111.088971. Epub 2012 May 24.

13.

Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.

Ruwald MH, Solomon SD, Foster E, Kutyifa V, Ruwald AC, Sherazi S, McNitt S, Jons C, Moss AJ, Zareba W.

Circulation. 2014 Dec 23;130(25):2278-86. doi: 10.1161/CIRCULATIONAHA.114.011283. Epub 2014 Oct 9.

14.

Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association.

Mairesse GH, Braunschweig F, Klersy K, Cowie MR, Leyva F.

Europace. 2015 May;17(5):814-8. doi: 10.1093/europace/euu390. Epub 2015 Feb 20.

PMID:
25713012
15.
16.

Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.

Wilcox JE, Fonarow GC, Zhang Y, Albert NM, Curtis AB, Gheorghiade M, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW.

Circ Heart Fail. 2014 Jan;7(1):146-53. doi: 10.1161/CIRCHEARTFAILURE.113.000789. Epub 2013 Oct 31.

18.

Electrical storm and heart failure worsening in implantable cardiac defibrillator patients.

Guerra F, Flori M, Bonelli P, Patani F, Capucci A.

Europace. 2015 Feb;17(2):247-54. doi: 10.1093/europace/euu298. Epub 2014 Oct 26.

PMID:
25345831
19.

Nonhemodynamic parameters from implantable devices for heart failure risk stratification.

Boehmer JP.

Heart Fail Clin. 2015 Apr;11(2):191-201. doi: 10.1016/j.hfc.2014.12.001. Review.

PMID:
25834969
20.

Remote Active Monitoring in Patients with Heart Failure (RAPID-RF): design and rationale.

Saxon LA, Boehmer JP, Neuman S, Mullin CM.

J Card Fail. 2007 May;13(4):241-6.

PMID:
17517341

Supplemental Content

Support Center